Literature DB >> 24343535

[Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions].

Rogelio Domínguez-Moreno, Paulina Tolosa-Tort, Anais Patiño-Tamez, Alejandra Quintero-Bauman, Deisy K Collado-Frías, María G Miranda-Rodríguez, Obet J Canela-Calderón, Pablo Hurtado-Valadez, Raúl de Gante-Castro, Karoll M Ortiz-Guillén, Bruno Estañol-Vidal, Horacio Sentíes-Madrid, Guillermo García-Ramos, Carlos Cantú-Brito, José Luis Ruiz-Sandoval, Erwin Chiquete1.   

Abstract

INTRODUCTION: Guillain-Barré syndrome (GBS) is a neurological emergency representing the main cause of flaccid paralysis around the world, affecting all age groups. Little is known about the essential epidemiology of GBS in most Latin American countries. AIM: To determine the mortality associated with the diagnosis of GBS in hospital discharges during 2010 in hospitals of the Ministry of Health, Mexico. PATIENTS AND METHODS: We analyzed the database of hospital discharges of institutions pertaining to the Ministry of Health. Study cases were identified by the code G61.0 of the International Classification of Diseases, 10th revision (ICD-10). We excluded records of patients younger than 18 years and patients without complete demographic information.
RESULTS: During the year 2010 there were 2,634,339 discharges from hospitals of the Ministry of Health. We identified a total of 467 hospitalizations due to GBS in adults (median age: 41 years; 62.1% male) from 121 health institutions of the 32 Republic States. The highest frequency of GBS hospitalizations occurred during summer and fall. The median hospital stay was 8 days. The hospital mortality rate was 10.5%. The probability of death was directly associated with age, without a particular trend regarding gender, hospital care or state.
CONCLUSIONS: In 2010 GBS hospital mortality in this part of the Mexican health system was higher than that reported in contemporary studies. A seasonal association was observed regarding the frequency of hospitalizations for GBS.

Entities:  

Mesh:

Year:  2014        PMID: 24343535

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  8 in total

1.  Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome.

Authors:  Edinson Dante Meregildo-Rodriguez; Victor Hugo Bardales-Zuta
Journal:  Infez Med       Date:  2021-12-10

2.  Prognostic Factors in Elderly Patients With Guillain-Barré Syndrome: Does Age Matter?

Authors:  Maria Eugenia Briseño-Godínez; Antonio Arauz; Juan Carlos López-Hernández; Adib Jorge de Saráchaga; Esther Y Pérez-Valdez; Raúl Nathanael May-Más; Gabriela López-Hernández; Lisette Bazán-Rodriguez; Javier Andrés Galnares-Olalde; Elizabeth León-Manríquez; Edwin Steven Vargas-Cañas
Journal:  Neurohospitalist       Date:  2021-03-22

Review 3.  Guillain-Barré syndrome in Colombia: where do we stand now?

Authors:  María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 4.  Neurological manifestations of Zika virus infection.

Authors:  Ana-Belén Blázquez; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2016-11-12

5.  Long-term outcomes of Guillain-Barré syndrome possibly associated with Zika virus infection.

Authors:  Diana M Walteros; Jesus Soares; Ashley R Styczynski; Joseph Y Abrams; Jose I Galindo-Buitrago; Jorge Acosta-Reyes; Elsa Bravo-Ribero; Zuleima E Arteta; Alma Solano-Sanchez; Franklyn E Prieto; Maritza Gonzalez-Duarte; Edgar Navarro-Lechuga; Jorge L Salinas; Ermias D Belay; Lawrence B Schonberger; Inger K Damon; Martha L Ospina; James J Sejvar
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

Review 6.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

Review 7.  Zika Virus: the Latest Newcomer.

Authors:  Juan-Carlos Saiz; Ángela Vázquez-Calvo; Ana B Blázquez; Teresa Merino-Ramos; Estela Escribano-Romero; Miguel A Martín-Acebes
Journal:  Front Microbiol       Date:  2016-04-19       Impact factor: 5.640

8.  Intracellular translocation of HMGB1 is important for Zika virus replication in Huh7 cells.

Authors:  Kim-Ling Chin; Nurhafiza Zainal; Sing-Sin Sam; Pouya Hassandarvish; Rafidah Lani; Sazaly AbuBakar
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.